# Nuclide record mcrpc-mhspc (term). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/terms/mcrpc-mhspc/>
  a schema:DefinedTerm ;
  nuclide:kind "term" ;
  schema:identifier "mcrpc-mhspc" ;
  schema:name "mCRPC and mHSPC (castration-resistant vs hormone-sensitive prostate cancer)"@en ;
  schema:alternateName "castration-resistant"@en, "castration resistant"@en, "castrate-resistant"@en, "mCRPC"@en, "nmCRPC"@en, "CRPC"@en, "castration-sensitive"@en, "castration sensitive"@en, "hormone-sensitive"@en, "hormone sensitive"@en, "mHSPC"@en, "mCSPC"@en, "HSPC"@en, "hormone-naive"@en, "hormone-refractory"@en, "biochemical recurrence"@en, "PSA recurrence"@en, "rising PSA"@en, "PSA progression"@en, "rPFS"@en ;
  schema:description "Prostate cancer starts out fed by testosterone (hormone-sensitive) and shrinks when it is removed. When it learns to grow despite castrate testosterone levels it is called castration-resistant, a later and more dangerous stage with its own treatments."@en ;
  schema:url <https://nuclide.cc/terms/mcrpc-mhspc/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Prostate_cancer#Castration-resistant_prostate_cancer> ;
  schema:citation <https://en.wikipedia.org/wiki/Prostate_cancer#Castration-resistant_prostate_cancer> ;
  nuclide:related <https://nuclide.cc/terms/arpi/>, <https://nuclide.cc/isotopes/lu-177/>, <https://nuclide.cc/isotopes/ra-223/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/> ;
  nuclide:drugs <https://nuclide.cc/drugs/abiraterone/>, <https://nuclide.cc/drugs/enzalutamide/> ;
  nuclide:trials <https://nuclide.cc/trials/stampede/>, <https://nuclide.cc/trials/vision/>, <https://nuclide.cc/trials/psmafore/> .